Safe Use of Imported Sterile Fluids

ACPE Activity Number:  NONE
Release Date: December 5, 2024
Expiration Date: June 5, 2025
CE Credits: NONE
Activity Fee: Free of charge 

Activity Overview

In response to national shortages of sterile fluids, the FDA has authorized Baxter to import products from facilities around the world. Imported products can vary in appearance, barcode presence, and language compared to equivalent products approved for use in the United States. Additionally, there are important clinical differences between glucose and dextrose that clinicians should consider before using.

This one-hour webinar hosted by ASHP as part of the End Drug Shortages Alliance reviews important differences between imported products and their United States equivalents. Speakers describe resources available to safely navigate the differences in appearance, language, and concentrations. Two health system representatives share strategies used on the front lines to prevent medication errors associated with imported products.

Faculty

• Michael Ganio, PharmD, MS, BCSCP, FASHP, Senior Director, Pharmacy Practice and Quality, ASHP
• Kaleem Qureshi, Senior Director, Marketing, Clinical Nutrition, Baxter
• Rita Jew, PharmD, MBA, BCPPS, FASHP, President, Institute for Safe Medication Practices
• Kayla Waldron, PharmD, MS, BCPS, FASHP, Director, Medication Use and Quality Improvement, ASHP
• Daniel Dangler, PharmD, BCPS, Associate Vice President of Strategic Sourcing, Pharmacy Advocate Health
• Felicia Britt, PharmD, MS, BCPS, Clinical Manager, Compounding & Perioperative Services, University of North Carolina Health

There is no educational credit associated with this presentation